N-cyclopropyl-6-[(6,7-dimethoxyquinolin-4-yl)oxy]naphthalene-1-carboxamide

N-cyclopropyl-6-[(6,7-dimethoxyquinolin-4-yl)oxy]naphthalene‑1‑carboxamide is a synthetic small molecule compound with the molecular formula C25H22N2O4. It is listed in pharmaceutical compound libraries and referenced as VEGFR-IN-V in some chemical databases. The structure features a naphthalene carboxamide core substituted with a cyclopropyl group and an ether-linked dimethoxyquinoline moiety. While it appears in drug screening collections (such as ZINC15), there is no evidence of clinical development or approval for any therapeutic indication. Its mechanism of action has not been explicitly described in the available literature; however, based on its code name (VEGFR-IN-V), it may have been designed or investigated as an inhibitor of vascular endothelial growth factor receptor (VEGFR), which are targets commonly explored for antiangiogenic cancer therapies[2][1][7]. No information about clinical trials or marketed products was found.

Other names

N-cyclopropyl-6-(6,7-dimethoxyquinolin-4-yloxy)-1-naphthamide1-naphthalenecarboxamide, N-cyclopropyl-6-(6,7-dimethoxyquinolin-4-yloxy)-861874-34-2MFCD18206810MFCD-18206810MFCD 18206810